Back to trial detailsIntake questionnaire
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Applying to Stanford University Medical Center · Redwood City, California
Answer a few short questions to share with the research team.
0 of 3 answered